Riverview Trust Company’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-471
| Closed | -$36.6K | – | 670 |
|
|
2024
Q4 | $36.6K | Buy |
471
+8
| +2% | +$622 | 0.03% | 272 |
|
|
2024
Q3 | $31K | Buy |
463
+232
| +100% | +$15.6K | 0.03% | 319 |
|
|
2024
Q2 | $26.2K | Hold |
231
| – | – | 0.02% | 349 |
|
|
2024
Q1 | $32K | Buy |
+231
| New | +$32K | 0.02% | 319 |
|
|
2023
Q4 | – | Sell |
-165
| Closed | -$15.4K | – | 245 |
|
|
2023
Q3 | $15.4K | Hold |
165
| – | – | 0.01% | 515 |
|
|
2023
Q2 | $21.2K | Hold |
165
| – | – | 0.02% | 340 |
|
|
2023
Q1 | $19.2K | Hold |
165
| – | – | 0.02% | 357 |
|
|
2022
Q4 | $19K | Hold |
165
| – | – | 0.02% | 346 |
|
|
2022
Q3 | $13K | Buy |
+165
| New | +$13K | 0.01% | 501 |
|
|
2022
Q2 | – | Sell |
-192
| Closed | -$25K | – | 746 |
|
|
2022
Q1 | $25K | Buy |
+192
| New | +$25K | 0.02% | 384 |
|